Elixinol Wellness Limited
ELLXF
$0.01
$0.01248.78%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -990.70K | -970.10K | 336.90K | 346.40K | -908.10K |
| Total Depreciation and Amortization | 163.70K | 160.30K | 164.50K | 169.20K | 176.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 384.00K | 376.10K | 73.00K | 75.00K | 24.40K |
| Change in Net Operating Assets | -- | -- | -1.01M | -1.03M | -- |
| Cash from Operations | -443.00K | -433.80K | -431.40K | -443.60K | -706.80K |
| Capital Expenditure | -4.20K | -4.10K | -4.90K | -5.00K | -14.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -153.50K | -157.80K | -593.10K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.40K | -5.30K | 0.00 | 0.00 | 746.30K |
| Cash from Investing | -9.60K | -9.40K | -158.30K | -162.80K | 138.40K |
| Total Debt Issued | 699.00K | 699.00K | 430.50K | 430.50K | -- |
| Total Debt Repaid | -47.50K | -47.50K | -434.50K | -434.50K | -86.00K |
| Issuance of Common Stock | 75.00K | 75.00K | 747.50K | 747.50K | 1.58M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00K | -6.00K | -84.50K | -84.50K | -197.50K |
| Cash from Financing | 461.60K | 452.00K | 429.40K | 441.60K | 855.70K |
| Foreign Exchange rate Adjustments | -6.10K | -6.00K | -2.30K | -2.30K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.90K | 2.80K | -162.60K | -167.20K | 286.30K |